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ABSTRACT
Introduction: Low vaccine coverage is a major public
health concern, the consequences of which contribute
to around 1.5 million child deaths from vaccine-
preventable diseases. Thus, innovative strategies to
rapidly increase coverage and recall rates for
vaccinations are urgently required. Mobile text
messaging (or short messaging service, SMS) has the
potential to help increase vaccination coverage and
therefore we propose to conduct a review of the
current best evidence for the use of SMS as an
intervention to promote vaccination coverage.
Methods and analysis: This article describes the
protocol for a systematic review of the effectiveness of
SMS in improving the uptake of vaccination. Primary
and secondary outcomes of interest are prespecified.
We will preferably include randomised controlled trials
(RCTs). However, non-randomised studies (NRS) will
be considered if there is an inadequate number of
RCTs. We will search several bibliographic databases
(eg,PubMed, EMBASE, CINAHL, CENTRAL, Science
Citation Index, Africa-Wide Information and WHOLIS
electronic databases and search sources for grey
literature. Following data extraction and assessment of
risk of bias, we will meta-analyse studies and conduct
subgroup analyses, according to intervention subtypes.
We will assess clinical heterogeneity and statistical
heterogeneity. For outcomes without quantitative data,
a descriptive analysis will be used. This review protocol
is registered in the PROSPERO International
Prospective Register of systematic reviews, registration
number 2014:CRD42014007531
Ethics and dissemination: Ethics is not required for
this study, given that this is a protocol for a systematic
review, which uses published data. The findings of this
study will be disseminated through peer-reviewed
publications and conference presentations. We
anticipate that the results could be used by researchers
and policymakers to help inform them of the efficacy of
mobile phone text messaging interventions to promote
increased vaccination coverage.
Trial registration number: PROSPERO registration
number 2014:CRD42014007531.
INTRODUCTION
Vaccinations, when given at the most sensi-
tive developmental years of childhood, help
to promote comprehensive and capable
immunity, enabling children to ﬁght off
certain diseases.1 2 In addition, vaccinations
are widely regarded as one of the most cost-
effective public health interventions that
help to reduce global child morbidity and
mortality.3 4 Low coverage of vaccinations is a
major public health concern. In Africa
alone, more than seven million children did
not receive the full spectrum of vaccinations
recommended before reaching 1 year of age
in 2009.5 It is also estimated that 1.5 million
children died globally from vaccine-
preventable diseases where WHO pre-
qualiﬁed vaccines were available.6
The Global Vaccine Action plan (GVAP) is
the most recently launched global effort by
the WHO to help increase vaccination cover-
age. The GVAP has set a target that by 2020
vaccination coverage for populations should
reach 90% national vaccination coverage and
at least 80% at district levels utilising national
vaccination programmes.7 It is guided by six
principles: country ownership, shared
responsibility and partnership, equity, inte-
gration, sustainability and innovation.8
A variety of factors impact achieving low
coverage rates; challenges such as immunisa-
tion awareness, demand for immunisation,
level of trust in the health system, adequate
Strengths and limitations of this study
▪ To our knowledge, this is the first systematic
review protocol that will attempt to assess the
impact of mobile text messaging on promoting
the uptake of vaccination among adults, adoles-
cents and parents or caregivers of children.
▪ This study will help inform clinical practice and
future studies on the effectiveness of media
platforms.
▪ Non-randomised studies of low-quality evidence
may be this study’s limitation. We will, however,
conduct appropriate analyses to assess the
overall robustness of the results.
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human resources, access, timeliness of vaccinations,
service delivery, poor infrastructure and vaccination
monitoring.4 Vaccination coverage seems to be lower in
low-income households, where limited access to health
education, contributes to poor health-seeking behaviour
along with an inability to improve general well-being.1 2 9
Uneducated parents therefore are less likely to
understand the importance of vaccinating to prevent
potentially harmful diseases. In light of these obstacles
to vaccination coverage, the strategy to improve
vaccination coverage needs to be innovative as alluded
to in the GVAP, well thought out and able to penetrate
low-income households effectively.
Globally, mobile phone use is rapidly increasing, with
an estimated six billion mobile phone users worldwide
at the end of 2011.10 In particular, mobile phone text
messaging has gained popularity among people living in
low-income and middle-income countries and may be
the key to penetrating hard to reach areas in the devel-
oping world. Text messaging has proven to be a cost-
effective method of relaying health information and
reminders than the more traditional methods such as
face-to-face, phone calls, pamphlets, mail and email.5 As
immunisation usually requires multiple consecutive
monthly visits after the ﬁrst vaccine dose in order to
complete the schedule, short messaging service (SMS)
can be used as reminder for an upcoming visit and
recall when a visit has been missed.1 In addition, an
SMS intervention, also known as mobile phone text mes-
saging, can be delivered alone or bundled with other
interventions.11 Diseases that have used mobile technol-
ogy successfully include HIV where a 90% adherence
was observed among text message recipients compared
with a 40% adherence in the control group.12 We there-
fore propose to conduct a systematic review of the
current best evidence for the use of mobile phone text
messaging to improve vaccination coverage.
METHODS
This review protocol has been published in the
PROSPERO International Prospective Register of system-
atic reviews (http://www.crd.york.ac.uk/PROSPERO),
registration number 2014:CRD42014007531. The
methods for this review will follow those published
previously.13
Criteria for considering studies for this review
Type of studies
We will include randomised controlled trials (RCTs),
interrupted time series and controlled before and after
studies.
Types of participants
Participants will be caregivers of infants or children, ado-
lescents and adults including pregnant women drawn
from any setting, community-based or otherwise.
Types of interventions
We will include interventions in which mobile phone
text messages serve as a reminder to be vaccinated, as
educational information or, as information regarding
vaccine availability at the clinic in an attempt to
promote uptake of vaccinations. Vaccinations could
include routine infant immunisations, those against
human papilloma virus, inﬂuenza, meningococcal or
tetanus/diptheria/accellular pertussis. Eligible studies
will be those that compared SMS to no intervention, or
to other interventions for increasing vaccination cover-
age. If we ﬁnd less than 10 studies that include only SMS
as the intervention, we will include studies in which
mobile phone voice speaking or voice messaging are
interventions; studies in which the use of a beeper or
pager is the intervention; studies in which the use of
multimedia messaging service is the intervention; and
studies in which text messages are bundled with other
interventions. In such circumstances, we will stratify the
analysis by type of intervention.
Types of outcome measures
Results must include quantitative data for outcomes
measured.
Primary outcomes
The primary outcome is vaccination coverage, irrespect-
ive of disease. We will use the deﬁnition of vaccine cover-
age as stipulated by the respective authors.
Secondary outcomes
Secondary outcomes are the recall rate in persons who
had previously missed their vaccinations, scheduled
appointments for vaccination or completeness of vaccin-
ation records.
Search methods for identification of studies
A comprehensive and exhaustive search of databases
and conference proceedings will be performed by RK
with the help of the University of Cape Town librarian,
to identify all relevant studies available by 30 June 2014,
regardless of language or publication status. We will
search both peer-reviewed journal articles and grey lit-
erature (unpublished, internal or non-reviewed papers
and reports).
Database
We will search the following electronic databases: PubMed;
EMBASE; Cochrane Central Register of Controlled Trials
(CENTRAL); ISI Web of Science (Science Citation Index);
Africa-Wide Information, Cumulative Index of Nursing
and Allied Health (CINAHL) and WHO library databases
(WHOLIS). We will use both text words and medical
subject heading (MeSH) terms; for example vaccination*,
immunization*, immunisation*, “Immunization”(MeSH),
“Vaccination”(MeSH), “Immunization, Secondary”(MeSH)
OR “Immunization Programs”(MeSH), “Immunization
Schedule”(MeSH), “Mass Vaccination”(MeSH), mobile
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phone, text messaging, text*, SMS, reminder*, recall, tele-
medicine, mHealth and eHealth. These terms will be used
in varying combinations. The literature search strategy will
be adapted to suit each database. Table 1 shows the main
search strategy we will use.
Conference proceedings
We will search the following conference proceedings for
relevant abstracts: Vaccine and International Society for
Vaccines Congress, International African Vaccinology
Conference, Annual Vaccines Congress, Annual Con-
ference on Vaccine Research, World Congress on
Pediatric Infectious Diseases, International Pediatric
Association Conference, National Immunization
Conference and the Annual Infectious Diseases in
Children Symposium.
Searching other sources
For ongoing studies, we will search the WHO
International Clinical trials Registry Platform,
Clinicaltrials.gov, Pan African Clinical Trials Registry
(PACTR), and contact individual researchers working in
the ﬁeld as well as the following organisations: WHO,
Global Alliance for Vaccines and Immunisation, Center
for Disease Control and Prevention and mHealth
Alliance. We will also search the website of mHealth
Alliance and mHealth in the Low Resource Settings
resources database for eligible studies.
Reference lists
We will obtain reference lists of relevant studies identi-
ﬁed and the full-text articles reviewed for inclusion in
the review will be checked for additional information.
Data collection and analysis
The methods for data collection and analysis will be
based on the Cochrane Handbook of Systematic Reviews
for Interventions.14
Selection of studies for inclusion
We will construct a screening guide to ensure that the
inclusion criteria are adhered to and consistently
applied by all review authors. Two review authors (RK
and MEE), working independently, will screen the titles
and abstracts of all studies identiﬁed through the litera-
ture searches for eligibility. RK will obtain the full text of
studies deemed potentially eligible. The two authors
(RK and MEE) will independently assess the full text of
each article for eligibility, and compare their results and
resolve discrepancies by discussion and consensus, con-
sulting a third author (CSW) to resolve any persistent
disagreements. For all studies excluded by the assessors
we will describe the reasons for exclusion.
Assessment of risk of bias in included studies
Two authors will independently assess the risk of bias in
the included studies. Separate criteria will be used to
assess RCTs and non-randomised studies. The criteria
used to assess the risk of bias of in RCTs will be random
sequence generation; allocation concealment; blinding
of participants, study personnel; blinding of outcome
assessors; incomplete outcome data; selective outcome
reporting; other sources of bias and overall risk of bias,
in accordance with the methods used by the Cochrane
Collaboration14 as well as the Cochrane Consumers and
Communication Review Group.15 The criteria used for
risk of bias assessment for non-randomised studies will
include selection bias (with regard to comparability of
groups, confounding and adjustment); performance
bias (in terms of the ﬁdelity of the interventions and
quality of the information regarding who received which
interventions, including blinding of study participants
and healthcare providers); detection bias (regarding
unbiased and correct assessment of outcomes, including
blinding of assessors); attrition bias (with regard to com-
pleteness of sample, follow-up and data); and reporting
bias (with regard to publication biases and selective
reporting of results).14 Studies will be scored as having
low, high or unclear risk of bias. The two authors will
resolve disagreements in the assessment of risk of bias by
discussion and consensus, consulting a third author to
resolve any persistent disagreements.
Data extraction and management
References will be managed using Thomson ISI
Research-Soft Endnote V.9.0.16 Two authors will inde-
pendently extract descriptive and outcome data for each
included article using a standardised data collection
form, resolving any discrepancies by discussion and con-
sensus; failing which, a third author (CSW) will arbitrate.
RK will enter the ﬁnal data into the Cochrane
Collaboration Review Manager V.5.1 statistical software
(http://ims.cochrane.org/RevMan). CW will crosscheck
the data entered to ensure that there are no data entry
errors.
Data synthesis including assessment of heterogeneity
Data analysis will be conducted using the Cochrane
Collaboration Review Manager V.5.1 statistical software
(http://ims.cochrane.org/RevMan). The outcomes of
interest will be either dichotomous or continuous. We
Table 1 PubMed search strategy, modified as needed for
use in other databases
Search PubMed
#1 (immunization[Mesh]) OR ((immunis* OR
immuniz* OR vaccin*)
#2 (adolescents OR children OR teenagers)
#3 ‘SMS’ OR cellphone OR ‘mobile phone’ OR ‘text
messaging’ OR ‘short message service’ OR ‘text
reminder’
#4 #1 AND #2
#5 #3 AND #4
MeSH, medical subject heading.
Kalan R, et al. BMJ Open 2014;4:e005130. doi:10.1136/bmjopen-2014-005130 3
Open Access
group.bmj.com on July 30, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
will calculate risk ratios and their corresponding 95%
CIs and p values for dichotomous outcomes, and mean
differences and SDs for continuous outcomes. Where
outcomes are measured using different scales, we will
report standardised mean differences (SMD).17 In cases
of missing or incomplete information presented in the
included studies, we shall contact authors for further
information.
We will assess clinical heterogeneity by examining
types of participants, interventions and outcomes in
each study. We will pool data only from studies judged to
be clinically homogenous. Statistical heterogeneity in
each meta-analysis will be assessed using the χ2 test and
quantiﬁed using the I2 statistic.18 If studies are sufﬁ-
ciently homogenous (in terms of study populations,
interventions and outcomes), then we will pool the data
across studies and estimate summary effect sizes using a
ﬁxed-effects model. Otherwise, we will use the
random-effects model. Should heterogeneity remain sig-
niﬁcant, we will discuss the ﬁndings as a narrative
summary.
We will perform subgroup analyses by intervention
subtypes: long versus short messages; daily versus weekly
messages; short weekly messages versus long weekly mes-
sages; short daily messages versus long daily messages;
and two-way interactive communication versus one-way
communication.12 19 20 We will also stratify analysis by
study design (randomised controlled separate from non-
randomised studies) and intervention type (multiple
interventions involving text messaging separate from
text messaging alone). We will also conduct a subgroup
comparison of self-reported vaccination completion
versus veriﬁed clinic records as well as according to age
categories and country setting.
Finally, we will use the grading of recommendations
assessment, development and evaluation (GRADE)
approach21 to assess the quality of evidence for the
effectiveness of the SMS intervention. This method
results in an assessment of the quality of the body of evi-
dence as high, moderate, low or very low. Evidence is
considered of high quality if ‘further research is very
unlikely to change our conﬁdence in the estimate of
effect’; and moderate quality if ‘further research is likely
to have an important impact on our conﬁdence in the
estimate of effect and may change the estimate’. Low
quality evidence implies that ‘further research is very
likely to have an important impact on our conﬁdence in
the estimate of effect and is likely to change the esti-
mate’, and very low quality that ‘we have very little conﬁ-
dence in the effect estimate’.
Sensitivity analyses
Several sensitivity analyses will be performed: ﬁrst to
determine whether the study design (RCT vs non-
randomised study) could inﬂuence the results of the
meta-analysis; second, to evaluate whether the model of
the statistical method (random-effects vs ﬁxed-effects
model) could change the results and third, to
determine the impact of excluding studies with a high-
risk bias on the results, with emphasis on allocation con-
cealment, blinded outcome assessment and losses to
follow-up (with a cut-off of 25% loss to follow-up).
Reporting of this review
Findings in our systematic review will be presented in
several ways. Flow diagrams will be used to summarise
the study selection process. Funnel plots will be used to
assess publication bias if we identify 10 or more eligible
studies. The κ statistic22 will be used to assess agreements
between the full-text screening, data extraction and risk
of bias assessment by the two authors (RK and MEE).
GRADE summary of tables of ﬁndings, risk of bias tables
or graphs and forest plots will also be used where appro-
priate. The reporting of outcomes without quantitative
data will be descriptive. Lastly, we will provide a list of
excluded studies with reasons for exclusion.
Ethics and dissemination
Systematic reviews draw on publicly available data and
do not directly involve human participants, and there-
fore do not require formal ethical review.23 The study
protocol will be reviewed by supervisors with expertise in
methodology (systematic review) and submitted to the
University of Cape Town Departmental Research
Committee for approval.
The ﬁndings of this systematic review will have implica-
tions for policy, practice and research. We will discuss
the relevance of our ﬁndings to childhood immunisa-
tion programmes in Africa in the decade of vaccines
with emphasis on applicability, effects on equity, cost
implications and monitoring and evaluation. Our system-
atic review will provide evidence of whether policy-
makers can adopt mobile phone text messaging alone
or in combination with other interventions in efforts to
improve uptake of vaccines in national immunisation
programmes. It will also inform clinic or hospital man-
agers of how best to use the intervention to improve vac-
cination coverage. The systematic review may also
identify speciﬁc considerations that would need to be
taken into account for future studies, such as study loca-
tion, content and timing of messages, whether or not
parents or caregivers replied to text messages, how text
messages were sent (automated vs manual), indicators
for immunisation programmes, variety of text messages
sent (inclusion of jokes or lifestyle tips), duration of the
study, whether or not participants were provided with
the mobile handsets and sample size.24
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